Corrigendum to “HMGA1 expression in human hepatocellular carcinoma correlates with poor prognosis and promotes tumor growth and migration in in vitro models” [Neoplasia 18 (2016) 724–731]

• Mariacarla Andreozzi,
• Cristina Quintavalle,
• David Benz,
• Luca Quagliata,
• Matthias Matter,
• Diego Calabrese,
• Nadia Tosti,
• Christian Ruiz,
• Francesca Trapani,
• Luigi Tornillo,
• Alfredo Fusco,
• Markus H. Heim,
• Charlotte K.Y. Ng,
• Pierlorenzo Pallante,
• Luigi M. Terracciano,
• Salvatore Piscuoglio

Affiliations

Mariacarla Andreozzi

Institute of Pathology, University Hospital Basel, Basel, Switzerland; Address all correspondence to: Salvatore Piscuoglio or Luigi Maria Terracciano, Institute of Pathology, University Hospital Basel, Schoenbeinstrasse 40, 4031 Basel, Switzerland.

Cristina Quintavalle

Institute of Pathology, University Hospital Basel, Basel, Switzerland

David Benz

Institute of Pathology, University Hospital Basel, Basel, Switzerland

Luca Quagliata

Institute of Pathology, University Hospital Basel, Basel, Switzerland

Matthias Matter

Institute of Pathology, University Hospital Basel, Basel, Switzerland

Diego Calabrese

Department of Biomedicine, Hepatology Laboratory, University of Basel, Basel, Switzerland

Nadia Tosti

Institute of Pathology, University Hospital Basel, Basel, Switzerland

Christian Ruiz

Institute of Pathology, University Hospital Basel, Basel, Switzerland

Francesca Trapani

Institute of Pathology, University Hospital Basel, Basel, Switzerland

Luigi Tornillo

Institute of Pathology, University Hospital Basel, Basel, Switzerland

Alfredo Fusco

Institute of Experimental Endocrinology and Oncology (IEOS), National Research Council (CNR), and Department of Molecular Medicine and Medical Biotechnology (DMMBM), University of Naples “Federico II, Naples, Italy; National Cancer Institute-INCA, Rua Andrè Cavalcanti, 37-Centro, Rio de Janeiro, Brazil

Markus H. Heim

Department of Biomedicine, Hepatology Laboratory, University of Basel, Basel, Switzerland

Charlotte K.Y. Ng

Institute of Pathology, University Hospital Basel, Basel, Switzerland

Pierlorenzo Pallante

Institute of Pathology, University Hospital Basel, Basel, Switzerland; Institute of Experimental Endocrinology and Oncology (IEOS), National Research Council (CNR), and Department of Molecular Medicine and Medical Biotechnology (DMMBM), University of Naples “Federico II, Naples, Italy

Luigi M. Terracciano

Institute of Pathology, University Hospital Basel, Basel, Switzerland; Address all correspondence to: Salvatore Piscuoglio or Luigi Maria Terracciano, Institute of Pathology, University Hospital Basel, Schoenbeinstrasse 40, 4031 Basel, Switzerland.

Salvatore Piscuoglio

Institute of Pathology, University Hospital Basel, Basel, Switzerland; Address all correspondence to: Salvatore Piscuoglio or Luigi Maria Terracciano, Institute of Pathology, University Hospital Basel, Schoenbeinstrasse 40, 4031 Basel, Switzerland.